Skip to main content
. 2018 Mar 7;314(6):R883–R891. doi: 10.1152/ajpregu.00416.2017

Fig. 1.

Fig. 1.

Experiment protocol timeline. Cardiovascular parameters were monitored daily from protocol day −1 (baseline) through day 14 (end of protocol). DOCA, deoxycorticosterone acetate; TRDNx, total renal denervation; ARDNx, afferent-selective renal denervation.